Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Quantum Immunologics
company
About
Quantum Immunologics is engaged in the research, development, and production of immunologic treatment systems for breast cancers.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $2.20M
- Industries
- Biotechnology,Developer Platform,Health Diagnostics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Quantum Immunologics, Inc., a biotechnology company, engages in the research, development, and production of immunologic treatment systems for breast cancer. Its products include individualized cancer immunotherapy system, a system in which blood drawn from a patient is treated with a process and cells are injected back into the patient; cancer monitoring test that uses cancer immunotherapy to monitor blood levels of the immune response in a patient following treatment; and cancer screening test, a blood test. The company is based in Tampa, Florida.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.20M
Quantum Immunologics has raised a total of
$2.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 15, 2009 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 15, 2009 | Series A | $2.20M | 1 |
Mentor Capital Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Quantum Immunologics is funded by 1 investors.
Mentor Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Mentor Capital Partners
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
